News

TORONTO – After a rigorous competition, the ALS Society of Canada today announced the recipients of the 2019 research funding grants. Through the ALS Canada Research Program, the only dedicated source of ALS research funding in Canada, nearly $1.4 million will be…

ALS Research Update, October 2019 Welcome to the October 2019 ALS Research update. This month, you’ll learn about the progress researchers have made in: transforming the way clinical trials are conducted; understanding the roles that the microbiome and protein clumping…

Antibodies are produced by the immune system to protect the body against foreign invaders like bacteria and viruses. They work by binding to specific proteins on harmful agents and triggering their removal or destruction. Antibodies are…

Delivering promising treatments to the brain can be a challenge because our bodies have a specialized barrier, called the blood-brain barrier, that protects it from substances in the bloodstream. For people living with ALS, this means researchers need to develop…

What’s happening in the world of ALS research at this point in the year? Read about the progress researchers have made in developing new and better models to study ALS in the lab, insights gained into the progression of ALS…

This webinar is part two of a two part series that focuses on clinical trials for ALS in Canada and across the world. Dr. David Taylor, VP of Research at ALS Canada, continues to explore current ALS clinical…

Every day, more than 3,000 people and families throughout Ontario and Canada live with the realities of ALS, a devastating disease that takes away dreams, abilities, and lives. But for all ALS takes, it cannot take away our shared desire…

This webinar is part one of a two part series that focuses on clinical trials for ALS in Canada and across the world. Dr. David Taylor, VP of Research at ALS Canada, explores how clinical trials currently work,…